Table 1

Demographic data of subjects

Parameter
Sequence
N
Mean
SD
Median
Range

Age (years)
BE
20
23.9
3.65
23.5
20; 35

EA
20
25.1
5.01
24.0
20; 39

AEB
20
27.8
6.57
26.5
20; 45

Weight (kg)
BE
20
68.3
10.74
69.5
50; 90

EA
20
67.7
9.54
68.5
49; 82

AEB
20
67.9
10.48
68.0
52; 87

BMI (kg/m2) *
BE
20
22.8
2.40
23.0
19; 27

EA
20
22.9
2.29
23.0
19; 27

AEB
20
22.2
2.67
22.0
19; 27










Sequence
N
N (♀)
% (♀)
N (♂)
% (♂)

Female gender (%)
BE
20
7
35.0
13
65.0

EA
20
6
30.0
14
70.0

AEB
20
6
30.0
14
70.0

Demography and other baseline characteristics by treatment sequence (Pharmacokinetic population; N = 60). "A" refers to Nurofen® forte, "B" refers to Migränin® and "E" refers to Eudorlin® extra. * calculated from measured height (m) and weight (kg).

Bramlage and Goldis BMC Pharmacology 2008 8:18   doi:10.1186/1471-2210-8-18